Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2003 2
2004 6
2005 3
2006 1
2009 2
2010 3
2011 1
2012 2
2013 3
2014 5
2015 4
2016 2
2017 2
2018 1
2019 2
2020 2
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, Faluyi O, O'Reilly DA, Cunningham D, Wadsley J, Darby S, Meyer T, Gillmore R, Anthoney A, Lind P, Glimelius B, Falk S, Izbicki JR, Middleton GW, Cummins S, Ross PJ, Wasan H, McDonald A, Crosby T, Ma YT, Patel K, Sherriff D, Soomal R, Borg D, Sothi S, Hammel P, Hackert T, Jackson R, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Among authors: gillmore r. Lancet. 2017 Mar 11;389(10073):1011-1024. doi: 10.1016/S0140-6736(16)32409-6. Epub 2017 Jan 25. Lancet. 2017. PMID: 28129987 Free article. Clinical Trial.
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Barber S, Ryder WD, Ramage J, Davies LM, Bridgewater JA, Valle JW; Advanced Biliary Cancer Working Group. Lamarca A, et al. Among authors: gillmore r. Lancet Oncol. 2021 May;22(5):690-701. doi: 10.1016/S1470-2045(21)00027-9. Epub 2021 Mar 30. Lancet Oncol. 2021. PMID: 33798493 Free PMC article. Clinical Trial.
COX and cancer.
Mazhar D, Gillmore R, Waxman J. Mazhar D, et al. Among authors: gillmore r. QJM. 2005 Oct;98(10):711-8. doi: 10.1093/qjmed/hci119. QJM. 2005. PMID: 16170203 Review. No abstract available.
Exploiting T cell receptor genes for cancer immunotherapy.
Xue S, Gillmore R, Downs A, Tsallios A, Holler A, Gao L, Wong V, Morris E, Stauss HJ. Xue S, et al. Among authors: gillmore r. Clin Exp Immunol. 2005 Feb;139(2):167-72. doi: 10.1111/j.1365-2249.2005.02715.x. Clin Exp Immunol. 2005. PMID: 15654813 Free PMC article. Review.
Chemotherapy for trophoblastic disease: current standards.
Kendall A, Gillmore R, Newlands E. Kendall A, et al. Among authors: gillmore r. Curr Opin Obstet Gynecol. 2002 Feb;14(1):33-8. doi: 10.1097/00001703-200202000-00006. Curr Opin Obstet Gynecol. 2002. PMID: 11801874 Review.
WT1-targeted immunotherapy of leukaemia.
Xue S, Gao L, Gillmore R, Bendle G, Holler A, Downs AM, Tsallios A, Ramirez F, Ghani Y, Hart D, Alcock S, Tranter A, Stauss HJ, Morris E. Xue S, et al. Among authors: gillmore r. Blood Cells Mol Dis. 2004 Nov-Dec;33(3):288-90. doi: 10.1016/j.bcmd.2004.08.018. Blood Cells Mol Dis. 2004. PMID: 15528146
Managing prostate cancer.
Gillmore R. Gillmore R. Practitioner. 2004 Apr;248(1657):274-80. Practitioner. 2004. PMID: 15114817 Review. No abstract available.
Metastatic bone disease from an occult renal primary.
Woodhouse L, Watkins J, Navalkissoor S, Gillmore R. Woodhouse L, et al. Among authors: gillmore r. BMJ Case Rep. 2019 Apr 3;12(4):e227657. doi: 10.1136/bcr-2018-227657. BMJ Case Rep. 2019. PMID: 30948394 Free PMC article.
Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Barber S, Ryder WD, Ramage J, Davies LM, Bridgewater JA, Valle JW; Advanced Biliary Cancer Working Group. Lamarca A, et al. Among authors: gillmore r. Lancet Oncol. 2021 Jul;22(7):e288-e289. doi: 10.1016/S1470-2045(21)00341-7. Lancet Oncol. 2021. PMID: 34197751 No abstract available.
45 results